A patent review on cathepsin K inhibitors to treat osteoporosis (2011 – 2021) (2022)
Rocho, Fernanda dos Reis 
; Bonatto, Vinícius ; Lameiro, Rafael da Fonseca ; Lameira, Jerônimo ; Leitão, Andrei ; Montanari, Carlos Alberto
Source: Expert Opinion on Therapeutic Patents. Unidade: IQSC
Subjects: BIOQUÍMICA, OSTEOPOROSE, NITRILAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHO, Fernanda dos Reis et al. A patent review on cathepsin K inhibitors to treat osteoporosis (2011 – 2021). Expert Opinion on Therapeutic Patents, v. 32, n. 5, p. 561-573, 2022Tradução . . Disponível em: https://doi.org/10.1080/13543776.2022.2040480. Acesso em: 08 out. 2025.APA
Rocho, F. dos R., Bonatto, V., Lameiro, R. da F., Lameira, J., Leitão, A., & Montanari, C. A. (2022). A patent review on cathepsin K inhibitors to treat osteoporosis (2011 – 2021). Expert Opinion on Therapeutic Patents, 32( 5), 561-573. doi:10.1080/13543776.2022.2040480NLM
Rocho F dos R, Bonatto V, Lameiro R da F, Lameira J, Leitão A, Montanari CA. A patent review on cathepsin K inhibitors to treat osteoporosis (2011 – 2021) [Internet]. Expert Opinion on Therapeutic Patents. 2022 ; 32( 5): 561-573.[citado 2025 out. 08 ] Available from: https://doi.org/10.1080/13543776.2022.2040480Vancouver
Rocho F dos R, Bonatto V, Lameiro R da F, Lameira J, Leitão A, Montanari CA. A patent review on cathepsin K inhibitors to treat osteoporosis (2011 – 2021) [Internet]. Expert Opinion on Therapeutic Patents. 2022 ; 32( 5): 561-573.[citado 2025 out. 08 ] Available from: https://doi.org/10.1080/13543776.2022.2040480
